LIVINGSTON, NJ--(Marketwired - April 21, 2017) - Milestone Scientific Inc. (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced a webcast presentation with Dr. Sven-Marcus Beschnidt, a key opinion leader (KOL) in dentistry, sharing his personal experience with the Wand® and discussing its advantages and benefits in delivering unparalleled patient satisfaction and superior clinical and business practice outcomes. The webcast presentation is available on the Company's website at: http://www.milestonescientific.com/investors.html.
Dr. Beschnidt is one of Germany's top medical professionals and distinguishes himself with outstanding work in the fields of microsurgery, implantology and cosmetic dentistry. Dr. Beschnidt is a specialist in prosthodontics and a specialist in implantology. Since 1998, Dr. Beschnidt has given approximately 500 lectures, workshops and live-surgery courses concerning implantology and microsurgery. He is a member of the following academies and associations: European Academy of Esthetic Dentistry (EAED); German Association of Maxillofacial Surgeons (DGZMK); German Association of Prosthodontics and Dental Materials (DGPro); German Association of Dental Implantology (DGI); European Association of Dental Implantologists (BDIZ).
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website: www.milestonescientific.com.
The presentation contains forward-looking statements regarding the advantages of the Wand Dental Instrument. These statements represent the views and opinions of the presenter and may not represent the prevalent views and opinions of dental professionals, presently or in the future. The views and opinions of the presenter may be affected by future results of dental professionals utilizing the device, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2016. The forward-looking statements in this presentation are based upon reasonable beliefs as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason. Please note that, from time to time, Milestone may compensate its key opinion leaders for participation in and/or attendance at sponsored events on its behalf. Any such compensation is made without regard to the opinions and conclusions expressed by any such individual.